Drugs / Cross-Linked Polyelectrolyte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02079233 | May → Jul 2010 | — | Sorbent Therapeutics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cross-Linked Polyelectrolyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02079233 ↗ |
| Known as | CLP | “Cross-Linked Polyelectrolyte (CLP)” NCT02079233 ↗ |
| Route | Oral | “CLP was administered orally, in capsules, for 7 consecutive days.” NCT02079233 ↗ |